Search

Home > New FDA Approvals > 097 - Sincalide for Injection; Forbes article on refuse to file letters; non-opioid patch for post-herpetic neuralgia; March PDUFA dates.
Podcast: New FDA Approvals
Episode:

097 - Sincalide for Injection; Forbes article on refuse to file letters; non-opioid patch for post-herpetic neuralgia; March PDUFA dates.
Category: Science & Medicine
Duration: 00:11:50
Publish Date: 2018-03-01 07:00:00
Description:

March 1, 2018 

Please subscribe, rate and review if you like this podcast. Thank you! The podcast website is http://newfdaapprovals.com

1:24 MAIA pharmaceuticals announces the tentative approval by the FDA of its NDA for Sincalide for injection https://www.prnewswire.com/news-releases/maia-pharmaceuticals-announces-the-tentative-approval-by-the-fda-of-its-nda-for-sincalide-for-injection-300605478.html 4:18 How bad Is Celgene's FDA foul-up? Two decades of biotech history say it can't be good https://www.forbes.com/sites/matthewherper/2018/02/28/how-bad-is-celgenes-fda-foul-up-two-decades-of-biotech-says-it-cant-be-good/#3590fc6febd3

5:40 Non-opioid pain patch approved by FDA for post-herpetic neuralgia http://sorrentotherapeutics.com/press-releases-display-new/?id=9851

7:36 Attention biotech investors: mark your calendar for these March PDUFA dates https://m.benzinga.com/article/11259734?utm_referrer=https%3A%2F%2Fwww.google.com%2F

Brought to you by Nascent Medical. For assistance with medical writing, please email info@nascentmc.com.

Music credit: freemusicarchive.org/music/MindsEye/Yellow_Taxi/
Total Play: 0